{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:06:52Z","timestamp":1787580412004,"version":"build-2736575974"},"reference-count":62,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine, Pharmacy, Science and Technology, George Emil Palade of \u201cT\u00e2rgu Mure\u0219 Research","award":["510\/12\/17.01.2022"],"award-info":[{"award-number":["510\/12\/17.01.2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Common mental disorders are an underdiagnosed comorbidity, which can significantly worsen the prognosis of the main disease and decrease the quality of life. We aimed to investigate the prevalence of depression and anxiety in a cohort of irritable bowel syndrome with diarrhea (IBS-D) and ulcerative colitis (UC) patients and to evaluate the risk factors for their occurrence. Materials and Methods: A total of 112 patients were evaluated. Multivariable analysis was used to determine associations between patient factors and common mental disorders, evaluated with PHQ-9 and GAD-7 questionnaires. Results: We found a significantly higher prevalence of moderate and severe anxiety among patients with IBS-D, when compared with the UC group (p &lt; 0.01). Linear regression analysis revealed an inverse association between anti-TNF-alpha monoclonal antibodies treatment and a higher PHQ-9 score (p = 0.02). Multivariate analysis revealed that, in patients with UC, the presence of children has been associated with a higher GAD-7 score (p = 0.01), both individually and in combination with a higher duration of the disease. (p &lt; 0.01). For IBS-D, a combination of active employment status and religious belief, active employment status and higher educational level, as well as religious belief and the presence of children correlated with higher GAD-7 scores (p = 0.03, p = 0.03 and p = 0.02, respectively). Conclusions: Infliximab used in the treatment for UC improved the parameters of depression. Patients with UC who have university education and a longer duration of the disease are at increased risk of developing depression and anxiety, especially if they have children in care. Regarding IBS-D patients who have an active work status, religious beliefs and caregivers are at increased risk of developing anxiety.<\/jats:p>","DOI":"10.3390\/jcm14020499","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:28:31Z","timestamp":1736854111000},"page":"499","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Burden of Common Mental Disorders in Ulcerative Colitis and Irritable Bowel Syndrome Patients: An Analysis of Risk Factors"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-9109","authenticated-orcid":false,"given":"Danusia","family":"Onisor","sequence":"first","affiliation":[{"name":"Department of Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-3329","authenticated-orcid":false,"given":"Calin","family":"Avram","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Ruta","sequence":"additional","affiliation":[{"name":"Department Community Nutrition and Food Safety, Faculty of General Medicine, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Brusnic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Boeriu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6297-0378","authenticated-orcid":false,"given":"Mircea","family":"Stoian","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-1585","authenticated-orcid":false,"given":"Adrian","family":"Boicean","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-7460","authenticated-orcid":false,"given":"Maria","family":"Sasaran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics III, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"ref_1","unstructured":"(2024, November 01). Crohnscolitisfoundation. Available online: https:\/\/www.crohnscolitisfoundation.org\/patientsandcaregivers\/what-is-ibd\/ibs-vs-ibd."},{"key":"ref_2","first-page":"335","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: A prospective study","volume":"26","author":"Boeriu","year":"2018","journal-title":"Rev. Romana Med. Lab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12955-017-0611-2","article-title":"Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea","volume":"15","author":"Buono","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Saroj, A., Tripathi, A., Rungta, S., and Kar, S.K. (2024). Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India. Brain Sci., 14.","DOI":"10.3390\/brainsci14040393"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hu, S., Chen, Y., Chen, Y., and Wang, C. (2021). Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.714057"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Swiss IBD Cohort Study Group. Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease","volume":"14","author":"Pittet","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.crohns.2008.01.002","article-title":"Reconsidering the methodology of \u201cstress\u201d research in inflammatory bowel disease","volume":"2","author":"Keefer","year":"2008","journal-title":"J. Crohn\u2019s Colitis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ibd\/izaa030","article-title":"Mental health costs of inflammatory bowel diseases","volume":"27","author":"Szigethy","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1097\/MIB.0b013e318281f395","article-title":"The influence of depression on quality of life in patients with inflammatory bowel disease","volume":"19","author":"Zhang","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200101000-00015","article-title":"Psychiatric predictors of noncompliance in inflammatory bowel disease: Psychiatry and compliance","volume":"32","author":"Nigro","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/gutjnl-2021-325985","article-title":"Bidirectional brain\u2013gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis","volume":"71","author":"Fairbrass","year":"2022","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MPG.0b013e3182841263","article-title":"Psychosocial issues in pediatric inflammatory Bowel disease: Report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"56","author":"Mackner","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1152\/ajpregu.00298.2014","article-title":"Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-011-0521-8","article-title":"Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance","volume":"47","author":"Hamilton","year":"2012","journal-title":"J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/apt.12669","article-title":"The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: A cohort study","volume":"39","author":"Panara","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","first-page":"111","article-title":"Inflammatory bowel disease and anxiety: Links, risks, and challenges faced","volume":"8","author":"Bannaga","year":"2015","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1572-0241.2000.02012.x","article-title":"Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission","volume":"95","author":"Levenstein","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/ibd\/izaa349","article-title":"The relationship between symptoms of depression and anxiety and disease activity in IBD over time","volume":"27","author":"Marrie","year":"2021","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ibd\/izab136","article-title":"Swiss IBD Cohort Study Group. Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease","volume":"28","author":"Jordi","year":"2022","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.genhosppsych.2023.05.002","article-title":"The bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis","volume":"83","author":"Bisgaard","year":"2023","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Karl, J.P., Hatch, A.M., Arcidiacono, S.M., Pearce, S.C., Pantoja- Feliciano, I.G., Doherty, L.A., and Soares, J.W. (2018). Effect of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02013"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5009\/gnl16347","article-title":"Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study","volume":"11","author":"Bhandari","year":"2017","journal-title":"Gut Liver"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Fracas, E., Costantino, A., Vecchi, M., and Buoli, M. (2023). Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences?. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20136255"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4103\/IJPSYM.IJPSYM_46_17","article-title":"Anxiety and depression in irritable bowel syndrome","volume":"39","author":"Banerjee","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5009\/gnl.2011.5.1.29","article-title":"Anxiety, depression and quality of life in patients with irritable bowel syndrome","volume":"5","author":"Cho","year":"2011","journal-title":"Gut Liver"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2008.03847.x","article-title":"Irritable bowel syndrome and dyspepsia among women veterans: Prevalence andassociation with psychological distress","volume":"29","author":"Savas","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s10620-007-0101-1","article-title":"Abuse in women and men with and without functional gastrointestinal disorders","volume":"53","author":"Alander","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.neuroimage.2012.08.028","article-title":"Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome","volume":"63","author":"Berman","year":"2012","journal-title":"Neuroimage"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pranckeviciene, A., Saudargiene, A., Gecaite-Stonciene, J., Liaugaudaite, V., Griskova-Bulanova, I., Simkute, D., Naginiene, R., Dainauskas, L.L., Ceidaite, G., and Burkauskas, J. (2022). Validation of the patient health questionnaire-9 and the generalized anxiety disorder-7 in Lithuanian student sample. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263027"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population","volume":"46","author":"Decker","year":"2008","journal-title":"Med. Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"European Crohn\u2019s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of in flammatory bowel disease: Controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","article-title":"European Crohn\u2019s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects","volume":"13","author":"Sturm","year":"2019","journal-title":"J. Crohn\u2019s Colitis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: Disorders of gut-brain Interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Abu Sneineh, A., Haj Ali, S., Al-Masri, A., Diab, A., Aldweik, F., Darweesh, M., Qaisi, M., Alshakhatreh, O., Tamimi, T., and Rayyan, Y. (2022). Prevalence of anxiety and depressive symptoms in ulcerative colitis patients in Jordan and its relationship to patient-reported disease activity. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-11911-4"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/1735-1995.165962","article-title":"Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life","volume":"20","author":"Tabatabaeian","year":"2015","journal-title":"J. Res. Med. Sci."},{"key":"ref_41","first-page":"91","article-title":"Evaluation of the correlation between anxiety, depression and personality traits with immunologic markers (ANCAs) in ulcerative colitis","volume":"16","author":"Fakheri","year":"2011","journal-title":"Govaresh"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s43045-021-00154-0","article-title":"The psychological impact of inflammatory bowel disease as regards anxiety and depression: A single-center study","volume":"28","author":"Askar","year":"2021","journal-title":"Middle East Curr. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111904","DOI":"10.1016\/j.jpsychores.2024.111904","article-title":"Adverse childhood experiences and alexithymia intensity as predictors of temporal dynamics of functioning in individuals with irritable bowel syndrome: A three-wave latent transition analysis","volume":"187","author":"Rzeszutek","year":"2024","journal-title":"J. Psychosom. Res."},{"key":"ref_44","first-page":"e61118","article-title":"Impact of Depression on Irritable Bowel Syndrome (IBS)-Associated Gastrointestinal Symptoms: A Cross-Sectional Study in Makkah City, Saudi Arabia","volume":"16","author":"Bakry","year":"2024","journal-title":"Cureus"},{"key":"ref_45","first-page":"1","article-title":"Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: The ATLANTIS RCT","volume":"28","author":"Ford","year":"2024","journal-title":"Health Technol. Assess"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bosman, M., Vork, L., Jonkers, D., Snijkers, J., Topan, R., Aziz, Q., Midenfjord, I., Simren, M., Masclee, A., and Keszthelyi, D. (Am. J. Gastroenterol, 2024). Results from a psychometric validation study: Irritable bowel syndrome patients report higher symptom burden using end-of-day versus real-time assessment, Am. J. Gastroenterol, epub ahead of print.","DOI":"10.14309\/ajg.0000000000003091"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e33713","DOI":"10.1097\/MD.0000000000033713","article-title":"Anxiety and depression in patients with inactive inflammatory bowel disease: The role of fatigue and health-related quality of life","volume":"102","author":"Stroie","year":"2023","journal-title":"Medicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/smi.2493","article-title":"Emotional control, styles of coping with stress and acceptance of illness among patients suffering from chronic somatic diseases","volume":"30","author":"Janowski","year":"2014","journal-title":"Stress Health"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5009\/gnl15188","article-title":"Factors associated with anxiety and depression in korean patients with inactive inflammatory bowel disease","volume":"10","author":"Kim","year":"2016","journal-title":"Gut Liver."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/1516-4446-2014-1507","article-title":"Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel disease","volume":"37","author":"Freitas","year":"2015","journal-title":"Rev. Bras. De Psiquiatr."},{"key":"ref_52","first-page":"11","article-title":"Sociodemographic and Clinical Profiles of Patients with Irritable Bowel Syndrome: A Cross-sectional, Multicentric, Epidemiological Study in India","volume":"69","author":"Khanna","year":"2021","journal-title":"J. Assoc. Physicians India"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"17562848211033763","DOI":"10.1177\/17562848211033763","article-title":"Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: A 5-year analysis","volume":"14","author":"Rossel","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.52142\/omujecm.40.1.10","article-title":"Comparison of depression and anxiety in inflammatory bowel patients treated with anti-TNF or immune modulators","volume":"40","author":"Ekmen","year":"2023","journal-title":"J. Exp. Clin. Med. March"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1987779","DOI":"10.1080\/19490976.2021.1987779","article-title":"Depression and anxiety in patients with active ulcerative colitis: Crosstalk of gut microbiota, metabolomics and proteomics","volume":"13","author":"Yuan","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yao, L., Pan, L., Qian, M., Sun, W., Gu, C., Chen, L., Tang, X., Hu, Y., Xu, L., and Wei, Y. (2020). Tumor Necrosis Factor-\u03b1 Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.518837"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Thillard, E.M., Gautier, S., Babykina, E., Carton, L., Amad, A., Bouzille, G., Beuscart, J.-B., Ficheur, G., and Chazard, E. (2020). Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00513"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cgh.2020.07.013","article-title":"Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease","volume":"19","author":"Dolovich","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2018.04.111","article-title":"Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies","volume":"237","author":"Geng","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_60","first-page":"CD006913","article-title":"Psychological interventions for treatment of inflammatory bowel disease","volume":"2","author":"Timmer","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ibd.20050","article-title":"The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease","volume":"13","author":"Kunzendorf","year":"2007","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Thornicroft, G., and Tansella, M. (1996). The Composite International Diagnostic Interview: An Instrument for Measuring Mental Health Outcome?, Springer. Mental Health Outcome Measures.","DOI":"10.1007\/978-3-642-80202-7"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/499\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:28:41Z","timestamp":1759919321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020499"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020499","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}